The MyHPVscore test represents a successful translation of research from the laboratory to clinical practice. A Michigan ...

HPV-related throat cancers are rising, but risks can be lowered by avoiding tobacco, limiting alcohol, getting vaccinated, ...

A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

Efti stimulates both innate and adaptive immunity, enhancing the immune system's ability to target and destroy cancer cells ... recurrent/metastatic head and neck squamous cell carcinoma and a PD-L1 ...

Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...

BioAtla Inc (BCAB) showcases significant advancements in clinical trials while navigating financial hurdles and seeking strategic partnerships.

April is Head and Neck Cancer Awareness Month, a critical time to shine a spotlight on a disease that often goes undetected until it's too late. A stunning reversal of fortunes in Canada's ...

Today we specifically focused on the link between HPV and head and neck cancer. Dr. Akshay Patel, head and neck surgical oncologist and co-director of head and neck oncology at Hartford HealthCare ...

The incidence of Human Papillomavirus (HPV)–associated oropharyngeal ... School of Medicine and director of the Gleiberman Head and Neck Cancer Center at UC San Diego Moores Cancer Center.

Phase 1 dose-escalation study ongoing, dosed first three patients at 300 micrograms; data readout expected mid-2025 with dose expansion data readout anticipated 1H 2026Mecbotamab vedotin (Mec-V; ...